NCT03602612
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Myeloma-Multiple
Explore clinical trials studying Myeloma-Multiple. Study availability and eligibility vary by location and protocol.
6 public trials
0 recruiting studies
Myeloma-Multiple trial results
NCT02294487
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +23 more
- Locations
-
- Aurora Health Care Milwaukee, Wisconsin, United States
NCT04065789
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Haemek Medical Center Afula, Israel
- Barzilai Medical Center Ashkelon, Israel
- Soroka Medical Center Beersheba, Israel
- Bnai-Zion Medical Center Haifa, Israel
NCT03958656
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
NCT02215967
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Active, Not Recruiting
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
NCT04782687
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Maryland Oncology Hematology, P.A. Columbia, Maryland, United States
- New York Oncology Hematology, P.C. Albany, New York, United States